Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.

Merus jumps 30% in three months after its cancer combo therapy showed significant efficacy in a phase II head and neck squamous cell carcinoma study.

MSFT, BABA, and MRK lead today's top analyst picks, with AI, e-commerce, and cancer drug strategies in sharp focus.

Two Indian nationals were sentenced to 30 months in prison for smuggling counterfeit cancer drugs into the US.

In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...

Merck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for the Wall ...

Varda Space Industries has raised $187 million to accelerate drug development in space using microgravity technology.

Two brothers from India were each sentenced to 30 months in prison for a scheme to sell counterfeit and adulterated drugs in the United States, the U.S. Attorney’s Office for the Western District of ...

The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...

Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, ...

Current operations chief Renee Gala will succeed Bruce Cozadd at Jazz. Meanwhile, a key study of an Ultragenyx and Mereo drug ...